David Henry Mack - 03 Dec 2024 Form 4 Insider Report for PMV Pharmaceuticals, Inc. (PMVP)

Role
President and CEO, Director
Signature
/s/ Robert Ticktin, by power of attorney
Issuer symbol
PMVP
Transactions as of
03 Dec 2024
Net transactions value
+$58,013
Form type
4
Filing time
22 Jan 2025, 16:37:33 UTC
Previous filing
03 Oct 2024
Next filing
05 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PMVP Common Stock Options Exercise $48,628 +91,750 +21% $0.5300 534,210 03 Dec 2024 Direct
transaction PMVP Common Stock Options Exercise $9,386 +17,709 +3.3% $0.5300 551,919 03 Jan 2025 Direct
holding PMVP Common Stock 165,307 03 Dec 2024 See footnote F1
holding PMVP Common Stock 147,915 03 Dec 2024 See footnote F2
holding PMVP Common Stock 56,978 03 Dec 2024 See footnote F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PMVP Employee Stock Option (right to buy) Options Exercise $0 -91,750 -84% $0.000000 17,709 03 Dec 2024 Common Stock 91,750 $0.5300 Direct F4
transaction PMVP Employee Stock Option (right to buy) Options Exercise $0 -17,709 -100% $0.000000 0 03 Jan 2025 Common Stock 17,709 $0.5300 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares are held of record by the Stinson 2021 Irrevocable Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.
F2 The shares are held of record by the Mack/Mulligan 2020 Irrevocable Descendants' Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.
F3 The shares are held of record by the Mack/Mulligan 2020 Irrevocable Descendants' Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.
F4 The shares subject to the option are fully vested and immediately exercisable.